A Post-Pandemic Investment Boom?
Executive Summary Increased S&P 500 earnings expectations likely to help drive higher capex Portfolio managers prefer firms invest for the future Easy access to capital…
davidgoldstein
How To Start Investing Sustainably (Without Sacrificing Financial Return)
Although sustainable investments have been around for centuries, they are usually centered around individuals’ personal or religious beliefs. More commonly, in the capital markets, investors…
7 ‘A-Rated’ Small-Cap Stocks To Buy Now
Small companies can grow faster in this type of economy There’s little doubt that the U.S. economy going great guns right now. And one of…
The Top 7 Stocks To Buy For Under $20 In August
These seven top stocks to buy for under $20 in August won’t remain so affordable for long Cheap stocks are plentiful. Cheap stocks that also…
How Do You Make Money In Private Deals?
As investors, there’s one question we should know the answer to before committing any funds… No, it’s not the valuation or the deal terms (although…
7 Semiconductor Stocks To Buy For An Ongoing Chip Shortage
While it’s a cynical play, these chipmakers are profiting from unprecedented circumstances If you’ve been paying attention to used car prices, you might have noticed…
COVID-19 Vaccine Stocks: Is Inovio Still In Play?
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising pInovio Pharmaceuticals went from being…
All Psyched Up: A Current List Of Psychedelics Stocks To Watch
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising potential of psychedelic medicine drug…
2 Former Wall Street Pros Share Their 5 Innovative Stocks To Buy
At the recent Global Financial Summit, two former Wall Street professionals shared their picks for innovative stocks to buy for the opportunity to profit from…
When It Comes To These 2 Biopharma Stocks’ Near-Term Gains, Analysts Are Seeing (More Than) Double!
Today’s article highlights two clinical-stage biopharmaceutical stocks that analysts expect to more than double in the coming months — one engaged in discovering and developing…